Abstract
Antiphospholipid syndrome is an autoimmune disease characterized by presenting certain positive antibodies in serum and clinical manifestations that are explained by the hypercoagulable state and are expressed with lesions of a vascular, neurological, obstetric, dermatological, hematological and other nature. Its diagnosis is carried out using techniques or methods that are based on some criteria that obey a pattern and others that allow identifying patients who do not have positive antibodies or lack marked manifestations but who developed the syndrome, that is, they get out of the Pattern. The management consists largely of the use of anticoagulants or antiaggregants such as aspirin and is enhanced with the use of corticosteroids, promoting the correct development of pregnancy in pregnant women; It should be noted that there are treatments that prevent recurrent abortion characteristic of this disease such as progesterone, immunotherapy and other medications that block the release of substances from the immune system that induce complications, many others are currently under study, mainly in animals. Much remains to be known about the mechanisms of injury and the pathophysiology of the syndrome, but we can dream of a promising pharmacological future in terms of a significant reduction in abortions.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2021 Lorena Mazo Betancur